(MedPage Today) — The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced.
Aficamten is an allosteric and reversible inhibitor of cardiac myosin motor activity…
Here are excerpts from BINI's historic performance at Coachella! Source: www.philstar.com Medical Disclaimer: This content is shared for informational and...
Fake call centre duping buyers of weight-loss products busted, 11 arrested Source: www.thehindu.com Medical Disclaimer: This content is shared for informational and educational...
People living with HIV/AIDS put forward demands to all political parties Source: www.thehindu.com Medical Disclaimer: This content is shared for...
A friend who saw the status immediately alerted the Namma 112 Emergency Helpline; police found the 28-year-old man lying unconscious...
‘I’m in my mid-30s and worried I’m hitting perimenopause’: Can it really start this early? Source: indianexpress.com
Katseye made their Coachella debut a golden one. Source: www.philstar.com Medical Disclaimer: This content is shared for informational and educational...
